Aug 4, 2023 · VILTEPSO (viltolarsen) injection is a sterile, preservative-free, aqueous solution for intravenous administration. VILTEPSO is a clear and colorless solution. VILTEPSO is supplied in single-dose vials containing 250 mg/5 mL viltolarsen (50 mg/mL) in 0.9% sodium chloride.

6 days ago · Viltepso J code. Viltepso J code is J1427 J codes are used for medicines that are not taken orally and include injections, inhalations, and chemotherapies. J code are important for accurate and consistent coding for billing and reimbursement purposes. Your physician will need the Viltepso J code when filling out forms for your treatment.

Viltepso's mechanism of action is to “hide” exon 53, causing cells to bypass this exon and permitting the remaining exons (a portion of a gene) to fit together properly. This allows the body to form a shortened version of the dystrophin protein.

Jan 27, 2021 · Viltepso is administered as an intravenous infusion over 60 minutes. Viltepso has the potential to cause kidney toxicity. Kidney function should be monitored. Common adverse reactions (incidence ≥15% in include upper respiratory tract infection, injection site reaction, cough, and pyrexia. Development timeline for Viltepso

Viltepso (viltolarsen) is a member of the miscellaneous uncategorized agents drug class and is commonly used for Duchenne Muscular Dystrophy. The cost for Viltepso (50 mg/mL) intravenous solution is around $1,481 for a supply of 5 milliliters, depending on the pharmacy you visit.

Feb 3, 2025 · Some dosage forms listed on this page may not apply specifically to the brand name Viltepso. Applies to viltolarsen: intravenous solution. Serious side effects of Viltepso. Along with its needed effects, viltolarsen (the active ingredient contained in Viltepso) may cause some unwanted effects. Although not all of these side effects may occur ...

Información relativa al paciente del fármaco Viltepso revisada por un médico - incluye descripción, efectos secundarios (o reacciones adversas), posología e instrucciones de uso.

VILTEPSO is a clear and colorless solution. Do not use if the solution in the vials is discolored or particulate matter is present. Withdraw the calculated volume of VILTEPSO from the appropriate number of vials. If the volume of VILTEPSO required is less than 100 mL, dilution in 0.9% Sodium Chloride Injection, USP is required.

Feb 28, 2025 · Viltepso is given by a healthcare provider once every week by an intravenous, or IV infusion through a needle in the vein. The infusion takes about one hour. Viltepso studies. Viltepso (viltolarsen) was approved in August 2020 under the FDA accelerated approval program. This program allows patients to use a promising new drug while the company ...

Viltepso (viltolarsen) 250 mg/5 mL (50 mg/mL) injection Drugs.com Mobile App Access drug & treatment information, identify pills, check interactions and set up personal medication records.